Immunotherapy in Combination with Chemotherapy for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that lacks estrogen and progesterone receptors and does not overexpress the human epidermal growth factor receptor 2 (HER2). Previous treatment options for TNBC were limited to chemotherapy alone, resulting in a poor pati...
Enregistré dans:
| Autres auteurs: | , , |
|---|---|
| Format: | Artículo |
| Langue: | en_US |
| Publié: |
2023
|
| Sujets: | |
| Accès en ligne: | https://doi.org/10.2174/1389557523666230517152538 https://pubmed.ncbi.nlm.nih.gov/37198990/ |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
